ArticleBMC public health2025
Knowledge and risk perception of e-cigarettes and hookah among young adults in Anambra State, Nigeria.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vaping Among Malaysian Students 2022-2024: A Systematic Review of Prevalence, Awareness and Influencing Factors.The Malaysian journal of medical sciences : MJMS · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundE-cigarettes and hookah have gained significant popularity, particularly among young people in recent years, despite limited research on their safety and efficacy. Advertisements for these products are widespread across various media platforms, further increasing their popularity and raising awareness among young adults. This study aimed to assess the knowledge and risk perception of e-cigarettes and hookah among young adults in Anambra State, Nigeria.
methodThis descriptive cross-sectional study was conducted in three tertiary institutions, selected through simple random sampling from the three Senatorial Districts of Anambra State. Participants (n = 272), aged 18-35 years, were recruited using a multi-stage stratified random sampling technique. A self- administered, semi- structured questionnaires was shared amongst students of the three tertiary institutions that met the inclusion criteria. Descriptive statistics were generated, and chi-square tests were conducted to determine the level of significance at p < 0.05.
resultThe study showed that the majority of participants (66.7%) sourced their information about e-cigarettes and hookah primarily from the internet/media, although 58.5% reported never having seen these substances in person. Among the participants, 7.4% reported using both e-cigarettes and hookah, with the highest prevalence of use seen in the 25-29 age group. The first use of these substances commonly occurred in cafés/restaurants (7.4%) and nightclubs (6.6%). Majority (64.7%) perceived both e-cigarettes and hookah as equally harmful in terms of health risks, while 50.7% considered both substances equally addictive. Participants identified respiratory (65.4%) and cardiovascular (71.7%) diseases as the primary health risks associated with the use of these substances.
conclusionThis study demonstrates a high level of awareness of the health risks, addictive nature, and harmful effects of e-cigarette and hookah use among young adults in Anambra State. However, there appears to be a lack of in-depth, comprehensive understanding of the broader implications of these risks. The prevalence of use in social settings reveals the need for targeted, detailed education on their risks. Incorporating these products into smoke-free policies and regulating access in environments frequented by young adults are essential to curbing their growing use and associated health risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.